Key result
Group B Coxsackieviruses seroprevalence was 69.1% overall, with positivity significantly increasing from 25.2% in children aged 0-2 years to 70.4% in those aged 6-10 years.
Why the study?
Recent seroepidemiologic data on group B Coxsackieviruses (CVB) were lacking in Italy.
Observational (n=2,459)
No
There is a high overall seroprevalence of group B Coxsackieviruses in the Italian population, with children aged 0-10 years representing a highly susceptible group.
Answers are grounded in this paper and cite their sources.
Signals high susceptibility in young Italian children; leaves open clinical impact and need for longitudinal studies.
Group B Coxsackieviruses (CVB) include six serotypes (B1-6) responsible for a wide range of clinical diseases. Since no recent seroepidemiologic data are available in Italy, the study aim was to investigate CVB seroprevalence in a wide Italian population. The study retrospectively included 2459 subjects referring to a large academic hospital in Rome (Italy) in the period 2004-2016. Seroprevalence rates and neutralizing antibodies (nAb) titers were evaluated in relation to years of observation and subjects' characteristics. Positivity for at least one serotype was detected in 69.1% of individuals. Overall, the prevalent serotype was B4, followed by B3 (33.3%), B5 (26.2%), B1 (12.7%), B2 (11.0%), and B6 (1.7%). For B2, a significant decrease in seroprevalence over years was observed. Positivity to at least one virus was 25.2% in children aged 0 to 2 years, but significantly increased in preschool (3-5 years) (50.3%) and school (6-10 years) children (70.4%). Higher nAb responses for B3 and B4 were observed in children aged 3 to 5 years. A high overall CVB prevalence was found. Type-specific variations in prevalence over time probably reflect the fluctuations in circulation typical of Enteroviruses. Children are at greater risk for CVB infection given the high number of seronegative subjects aged 0 to 10 years.
No takes yet. Share an insight, caveat, or question.
Sciandra et al. (2020) conducted an observational in Group B Coxsackieviruses (CVB) infection (n=2,459). Group B Coxsackieviruses (CVB) exposure was evaluated on Positivity for at least one CVB serotype. Group B Coxsackieviruses seroprevalence was 69.1% overall, with positivity significantly increasing from 25.2% in children aged 0-2 years to 70.4% in those aged 6-10 years.
Synapse has enriched 10 related papers. Consider them for comparative context: